Natera to Present at the Morgan Stanley 18th Annual Global Healthcare Conference

Natera, Inc. (NASDAQ: NTRA) will present at the Morgan Stanley 18th Annual Global Healthcare Conference on September 14, 2020, at 9:00 a.m. PT (12:00 p.m. ET).

Rhea-AI Summary

Natera, Inc. (NASDAQ: NTRA) will present at the Morgan Stanley 18th Annual Global Healthcare Conference on September 14, 2020, at 9:00 a.m. PT (12:00 p.m. ET). The webcast will feature insights from Steve Chapman, CEO, and Mike Brophy, CFO, discussing recent developments and business activities. Interested parties can access the live presentation and archived content through investor.natera.com. Natera specializes in cell-free DNA testing, focusing on women's health, oncology, and organ health.

Argus Session date unavailable

-2.19% session move Open Argus

Details

News Market Reaction – NTRA

The recorded move for NTRA in the trading session of this news was -2.19%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SAN CARLOS, Calif., Sept. 10, 2020 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced it will webcast a live presentation at the Morgan Stanley 18th Annual Global Healthcare Conference taking place virtually on Monday, Sept. 14, 2020, at 9:00 a.m. PT (12:00 p.m. ET).

Steve Chapman, Chief Executive Officer, and Mike Brophy, Chief Financial Officer, will discuss Natera's latest developments and business activities.

Access to the live webcast and subsequent archived presentation will be available at investor.natera.com.

About Natera
Natera is a pioneer and global leader in cell-free DNA testing. The mission of the company is to change the management of disease worldwide with a focus on women's health, oncology, and organ health. Natera operates an ISO 13485-certified and CAP-accredited laboratory certified under the Clinical Laboratory Improvement Amendments (CLIA) in San Carlos, California. It offers proprietary genetic testing services to inform obstetricians, transplant physicians, oncologists, and cancer researchers, including biopharmaceutical companies, and genetic laboratories through its cloud-based software platform. For more information, visit natera.com. Follow Natera on LinkedIn. 

Contacts
Investor Relations: Mike Brophy, CFO, Natera, Inc., 510-826-2350
Media: Paul Greenland, VP of Corporate Marketing, pr@natera.com

View original content to download multimedia:http://www.prnewswire.com/news-releases/natera-to-present-at-the-morgan-stanley-18th-annual-global-healthcare-conference-301127899.html

SOURCE Natera, Inc.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What is Natera presenting at the Morgan Stanley conference?

Natera will present its latest developments and business activities at the Morgan Stanley 18th Annual Global Healthcare Conference on September 14, 2020.

When is Natera's presentation at the Morgan Stanley conference?

Natera's presentation is scheduled for September 14, 2020, at 9:00 a.m. PT (12:00 p.m. ET).

Who will speak at Natera's presentation?

Steve Chapman, CEO, and Mike Brophy, CFO, will speak during Natera's presentation.

How can I access Natera's conference presentation?

You can access the live presentation and archived content at investor.natera.com.

What does Natera specialize in?

Natera specializes in cell-free DNA testing, focusing on women's health, oncology, and organ health.